Democratizing healthcare with an AI-powered software that rapidly, affordably, and reliably diagnoses critical health conditions from medical images.

ChironX is a deep tech company solving healthcare diagnostics using AI, data science, and advanced image processing. Their innovative software solution works on differential diagnoses to detect complex diseases from medical images and mitigate uncertainty in interpretation—making it faster, cheaper, and more robust than traditional methods. The ChironX platform is positioned to serve across the board, significantly restructuring the workflow of hospitals for the better and reducing a doctor’s administrative work burden. While their initial go-to-market solution is retinal image processing, ChironX is actively researching and developing solutions for endocrinology, the cardiovascular system, neurology, Alzheimer’s, and Parkinson’s. Due to the nature of how systemic diseases manifest throughout the body, ChironX’s software is capable of detecting hundreds of diseases and complications from the retina with 95% accuracy. With this software, hospitals can see a 4-13% increase in revenue, while billions of patients across the globe can benefit from more affordable access to quality healthcare.

FOUNDED
2010

AREAS OF IMPACT
Health Infrastructure

HEADQUARTERS
Gurugram, Haryana, India

COMPANY SIZE
6–20

Mausumi Acharyya

Mausumi Acharyya (Founder, CEO) has been an Unreasonable Fellow since June 2018 after participating in Unreasonable Impact Asia Pacific 2018.

Unreasonable Impact Asia Pacific 2018
1
TERRITORIES OF OPERATION
$410k
MONEY RAISED

Connect with ChironX

Follow ChironX on social media below or view their open jobs on their careers page.

  • Featured VentureGeneral Fusion

  • Featured VentureAndiamo